Forbion to create and grow biotech companies Interviewee/Contributor Sander Slootweg and Juliette Audet Organisation Forbion Commentary Finance Strategy Read more about Forbion to create and grow biotech companies
Transatlantic partnerships in life science Interviewee/Contributor Olivier Litzka Organisation Andera Partners Commentary Finance Strategy Venture Capital Read more about Transatlantic partnerships in life science
Investors support new antifungal agent Interviewee/Contributor Ralf Schmid and Emma Harvey Organisation F2G Ltd Drug discovery Finance Venture Capital Read more about Investors support new antifungal agent
Pace of financing quickens for European biopharma Interviewee/Contributor Victoria English Organisation MedNous Finance Read more about Pace of financing quickens for European biopharma
Why private equity is investing in biopharma Interviewee/Contributor Emma Dabbs Organisation Novasecta Ltd Finance Management (biotech and Pharma) Strategy Read more about Why private equity is investing in biopharma
Three European biotechs raise nearly $6 billion Interviewee/Contributor Victoria English Organisation MedNous Finance Read more about Three European biotechs raise nearly $6 billion
Advanced therapy financing events in Q1 2019 Interviewee/Contributor Victoria English Organisation MedNous Finance Gene therapy Regenerative medicine (Stem cells) Read more about Advanced therapy financing events in Q1 2019
2018 Fourth quarter stock market review Interviewee/Contributor William Ellington Organisation MedNous Finance Stock market performance Read more about 2018 Fourth quarter stock market review
Light on the horizon for Swedish biopharma Interviewee/Contributor Søren Tulstrup Organisation Hansa Medical AB Drug discovery Finance Strategy Read more about Light on the horizon for Swedish biopharma
Altheia Science Srl: Italian biotech raises $11 mln for autoimmunity Interviewee/Contributor MedNous financing article Organisation Altheia Science Srl Drug discovery Finance Read more about Altheia Science Srl: Italian biotech raises $11 mln for autoimmunity